ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 179 filers reported holding ARGENX SE in Q3 2021. The put-call ratio across all filers is 0.49 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $131,265 | +26.1% | 267 | 0.0% | 0.00% | – |
| Q2 2023 | $104,058 | +4.6% | 267 | 0.0% | 0.00% | – |
| Q1 2023 | $99,478 | -1.7% | 267 | 0.0% | 0.00% | – |
| Q4 2022 | $101,148 | +7.6% | 267 | 0.0% | 0.00% | – |
| Q3 2022 | $94,000 | -98.2% | 267 | -98.1% | 0.00% | -100.0% |
| Q2 2022 | $5,217,000 | +58.3% | 13,770 | +31.7% | 0.01% | +100.0% |
| Q1 2022 | $3,296,000 | +19.0% | 10,454 | +32.2% | 0.00% | +50.0% |
| Q4 2021 | $2,770,000 | +15.9% | 7,910 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $2,389,000 | -9.0% | 7,910 | -9.2% | 0.00% | 0.0% |
| Q2 2021 | $2,624,000 | +34.6% | 8,715 | +23.1% | 0.00% | -33.3% |
| Q1 2021 | $1,950,000 | +63.0% | 7,080 | +74.1% | 0.00% | +50.0% |
| Q4 2020 | $1,196,000 | +12.1% | 4,066 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $1,067,000 | +16.5% | 4,066 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $916,000 | +4721.1% | 4,066 | +1255.3% | 0.00% | – |
| Q4 2017 | $19,000 | – | 300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 297,701 | $112,778,070 | 70.21% |
| Artia Global Partners LP | 85,204 | $32,277,831 | 12.30% |
| Avoro Capital Advisors LLC | 1,265,555 | $479,430,201 | 7.16% |
| DCF Advisers, LLC | 25,000 | $9,470,750 | 6.40% |
| Eagle Health Investments LP | 60,300 | $22,843,449 | 5.27% |
| Avidity Partners Management LP | 625,000 | $236,768,750 | 5.13% |
| Bellevue Group AG | 911,100 | $345,152,013 | 4.58% |
| Fairmount Funds Management LLC | 73,526 | $27,853,855 | 4.42% |
| Paradigm Biocapital Advisors LP | 89,556 | $33,926,499 | 3.98% |
| RTW INVESTMENTS, LP | 482,195 | $182,669,932 | 3.73% |